Inventor · disambiguated record
Olga De La Rosa
Also filed as: DE LA ROSA OLGA
6 granted patents·4 pending applications·1 citations·filing 2009–2020
66Inventor score
Files withTIGENIX S A U4BUESCHER DIRK2DE LA ROSA OLGA1GARCIA CASADO JAVIER1TAKEDA PHARMACEUTICALS CO1
Top patents by PatentIndex Score
10 records- 0167US10660920B2Lymphocyte biomarkers for determining the clinical response to cell therapyTIGENIX S A U·Filed 2014·Granted May 26, 2020·1 cites·16 claims
- 0261US11478511B2Lymphocyte biomarkers for determining the clinical response to cell therapyTIGENIX S A U·Filed 2020·Granted Oct 25, 2022·0 cites·16 claims
- 0349US9012220B2Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseasesBUESCHER DIRK·Filed 2009·Granted Apr 21, 2015·0 cites·3 claims
- 0437US11857575B2Mesenchymal stem cell-derived exosomes and their usesTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jan 2, 2024·0 cites·5 claims
- 0532US9969976B2Cell populations having immunoregulatory activity, methods for the preparation and uses thereofBUESCHER DIRK·Filed 2010·Granted May 15, 2018·0 cites·7 claims
- 0632US2014348808A1Cell populations having immunoregulatory activity, methods for the preparation and uses thereofDE LA ROSA OLGA·Filed 2012·Application pending·0 cites
- 0732US2017119682A1Mesenchymal stem cell-derived exosomes and their usesTIGENIX S A U·Filed 2016·Application pending·0 cites
- 0830US10746729B2Biomarkers for determining the clinical response to cell therapyTIGENIX SAU·Filed 2016·Granted Aug 18, 2020·0 cites·17 claims
- 0924US2017121685A1Mesenchymal stem cell-derived exosomes and their usesTIGENIX S A U·Filed 2015·Application pending·0 cites
- 1023US2014154227A1Cell populations having immunoregulatory activity, method for isolation and usesGARCIA CASADO JAVIER·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Olga De La Rosa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →